June 2015 Vol 6, No 3

Lillie D. Shockney, RN, BS, MAS, stresses how survivorship care plans can help measure the impact on patients’ ability to engage in self-management, make lifestyle changes, and be satisfied with having a sense of direction for future monitoring and screening.
The findings of this study highlight the importance of navigation services throughout the cancer journey and the value of the LIVESTRONG model. Because adequate psychosocial care is not available across many oncology care settings, services outside the clinical setting can help meet cancer survivors’ needs.
One barrier to cancer care we often forget to consider is psychosocial distress. We have excellent physicians, nurses, and clinic teams, using cutting-edge medical technology; however, if patients are internally struggling with life situations and circumstances, they sometimes will not follow through with their treatment plan.
Seven AONN+ members want you to know about a membership benefit that you might have overlooked. Did you know that there is a committee whose business is to help you do quality improvement projects and other forms of research, regardless of your level of experience in these areas?
I became a nurse almost by coincidence, even as I realize it was meant to be.
The objective of this study was to describe physical and functional impairments after cancer, and whether physical therapy was utilized to address impairments among cancer survivors from the Boston Puerto Rican Health Study.
The role of the nurse navigator in helping patients through the trajectory of their journey from diagnosis to treatment to survivorship has evolved, and in many settings, the nurse navigator has become a key component of a multidisciplinary approach to cancer care.
Advances in cancer treatment have led to a growing number of survivors, with 14.5 million survivors in 2014 and a projection of 19 million survivors by 2124. Survivorship care planning is now considered a quality metric, and survivorship care plans are a component of accreditation by the Commission on Cancer (CoC). Originally, the CoC stipulated that survivorship plans must be phased in by 2015; however, that date has been pushed to 2019, because this has been difficult to accomplish.
The following clinical trials are currently recruiting patients with renal-cell carcinoma for inclusion in several investigations. Each trial description includes the NLM Identifier to use as reference with ClinicalTrials.gov.
Page 1 of 2
Results 1 - 10 of 12

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State